Windtree Therapeutics Inc Share Price Nasdaq
Equities
US97382D1054
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.52M 210M |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.75B | Net income 2025 * | -29M -2.42B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.42
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.34% |
Latest transcript on Windtree Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/16/01 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/20/09 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/21/03 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/23/22 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/21/03 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |